{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:39:40Z","timestamp":1792787980438,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":83,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical Innovation Research of Shanghai Science and Technology"},{"name":"Shanghai Hospital Development Center","id":[{"id":"https:\/\/ror.org\/02zrtve16","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Eastern Talent Plan Project, the Simulated RCT study of Shanghai Shenkang Hospital Development Center"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16449-6","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:12:22Z","timestamp":1782875542000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effectiveness of radical surgery versus concurrent chemoradiotherapy in stages IB3, IIA2, or locally resectable IIICr cervical cancer: a prospective, multicenter, propensity score-matched cohort study"],"prefix":"10.1186","volume":"26","author":[{"given":"Qinqin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shugen","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqin","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"issue":"3","key":"16449_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"16449_CR2","doi-asserted-by":"publisher","first-page":"209","DOI":"10.21147\/j.issn.1000-9604.2018.02.04","volume":"30","author":"K Serkies","year":"2018","unstructured":"Serkies K, Jassem J. Systemic therapy for cervical carcinoma - current status. Chin J Cancer Res. 2018;30(2):209\u201321.","journal-title":"Chin J Cancer Res"},{"issue":"5","key":"16449_CR3","doi-asserted-by":"publisher","first-page":"e64","DOI":"10.3802\/jgo.2023.34.e64","volume":"34","author":"J Qiu","year":"2023","unstructured":"Qiu J, et al. A comparison of concurrent chemoradiotherapy and radical surgery in patients with specific locally advanced cervical cancer (stage IB3, IIA2, IIICr): trial protocol for a randomized controlled study (C-CRAL trial). J Gynecol Oncol. 2023;34(5):e64.","journal-title":"J Gynecol Oncol"},{"issue":"1","key":"16449_CR4","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/COC.0b013e31826103d0","volume":"37","author":"KM Doll","year":"2014","unstructured":"Doll KM, et al. Radical hysterectomy compared with primary radiation for treatment of stage IB1 cervix cancer. Am J Clin Oncol. 2014;37(1):30\u20134.","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"16449_CR5","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/IGC.0b013e31823f890f","volume":"22","author":"B Rungruang","year":"2012","unstructured":"Rungruang B, et al. Surgery versus radiation therapy for stage IB2 cervical carcinoma: a population-based analysis. Int J Gynecol Cancer. 2012;22(3):484\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"16449_CR6","first-page":"92","volume":"21","author":"M Yin","year":"2011","unstructured":"Yin M, et al. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer. Int J Gynecol Cancer. 2011;21(1):92\u20139.","journal-title":"Int J Gynecol Cancer"},{"issue":"2","key":"16449_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ygyno.2019.12.009","volume":"156","author":"J Yang","year":"2020","unstructured":"Yang J, et al. Comparing survival outcomes between surgical and radiographic lymph node assessment in locally advanced cervical cancer: A propensity score-matched analysis. Gynecol Oncol. 2020;156(2):320\u20137.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"16449_CR8","first-page":"94","volume":"42","author":"JD Wang","year":"2020","unstructured":"Wang JD, Kong WM, Jiang H. [FIGO 2018 staging of cervical cancer and related issues]. Zhonghua Zhong Liu Za Zhi. 2020;42(2):94\u20138.","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"issue":"20","key":"16449_CR9","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1056\/NEJMoa1806395","volume":"379","author":"PT Ramirez","year":"2018","unstructured":"Ramirez PT, et al. Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer. N Engl J Med. 2018;379(20):1895\u2013904.","journal-title":"N Engl J Med"},{"issue":"20","key":"16449_CR10","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1056\/NEJMoa1804923","volume":"379","author":"A Melamed","year":"2018","unstructured":"Melamed A, et al. Survival after Minimally Invasive Radical Hysterectomy for Early-Stage Cervical Cancer. N Engl J Med. 2018;379(20):1905\u201314.","journal-title":"N Engl J Med"},{"issue":"1","key":"16449_CR11","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10147-022-02262-1","volume":"28","author":"Y Huang","year":"2023","unstructured":"Huang Y, et al. Survival after laparoscopic radical surgery for stage IA-IIB cervical cancer: 1316 consecutive cases from a national laparoscopic training center in China. Int J Clin Oncol. 2023;28(1):175\u201383.","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"16449_CR12","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12957-023-03044-3","volume":"21","author":"X Lv","year":"2023","unstructured":"Lv X, et al. Effect of modified radical laparoscopic hysterectomy versus open radical hysterectomy on short-term clinical outcomes in early-stage cervical cancer: a single-center, prospective, randomized controlled trial. World J Surg Oncol. 2023;21(1):167.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"16449_CR13","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.3802\/jgo.2021.32.e10","volume":"32","author":"M Ceccaroni","year":"2021","unstructured":"Ceccaroni M, et al. Total laparoscopic vs. conventional open abdominal nerve-sparing radical hysterectomy: clinical, surgical, oncological and functional outcomes in 301 patients with cervical cancer. J Gynecol Oncol. 2021;32(1):e10.","journal-title":"J Gynecol Oncol"},{"key":"16449_CR14","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3389\/fonc.2019.01331","volume":"9","author":"W Wang","year":"2019","unstructured":"Wang W, et al. Laparoscopic vs. Abdominal Radical Hysterectomy for Locally Advanced Cervical Cancer. Front Oncol. 2019;9:1331.","journal-title":"Front Oncol"},{"key":"16449_CR15","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.3389\/fonc.2019.01107","volume":"9","author":"Z Yuan","year":"2019","unstructured":"Yuan Z, et al. Laparoscopic vs. Open Abdominal Radical Hysterectomy for Cervical Cancer: A Single-Institution, Propensity Score Matching Study in China. Front Oncol. 2019;9:1107.","journal-title":"Front Oncol"},{"issue":"4","key":"16449_CR16","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.1111\/jog.14693","volume":"47","author":"C Chen","year":"2021","unstructured":"Chen C, et al. Comparison of survival outcomes between laparoscopic surgery and abdominal surgery for radical hysterectomy as primary treatment in patients with stage IB2\/IIA2 cervical cancer. J Obstet Gynaecol Res. 2021;47(4):1516\u201326.","journal-title":"J Obstet Gynaecol Res"},{"key":"16449_CR17","doi-asserted-by":"publisher","first-page":"682849","DOI":"10.3389\/fonc.2021.682849","volume":"11","author":"W Zhao","year":"2021","unstructured":"Zhao W, et al. Survival Outcomes in Patients With 2018 FIGO Stage IA2-IIA2 Cervical Cancer Treated With Laparoscopic Versus Open Radical Hysterectomy: A Propensity Score-Weighting Analysis. Front Oncol. 2021;11:682849.","journal-title":"Front Oncol"},{"key":"16449_CR18","doi-asserted-by":"publisher","first-page":"889862","DOI":"10.3389\/fonc.2022.889862","volume":"12","author":"WW Wei","year":"2022","unstructured":"Wei WW, et al. Survival Impacts of Perineural Invasion on Patients Under Different Radical Hysterectomies Due to Early Cervical Cancer. Front Oncol. 2022;12:889862.","journal-title":"Front Oncol"},{"key":"16449_CR19","doi-asserted-by":"crossref","unstructured":"Agha RA, et al. Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence. Premier J Sci. 2025;10:100081.","DOI":"10.70389\/PJS.100081"},{"issue":"7","key":"16449_CR20","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1080\/03007995.2019.1571297","volume":"35","author":"RP Insinga","year":"2019","unstructured":"Insinga RP, et al. Cost-effectiveness of pembrolizumab in combination with chemotherapy versus chemotherapy and pembrolizumab monotherapy in the first-line treatment of squamous non-small-cell lung cancer in the US. Curr Med Res Opin. 2019;35(7):1241\u201356.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"16449_CR21","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1080\/03007995.2023.2178081","volume":"39","author":"Z Zheng","year":"2023","unstructured":"Zheng Z, et al. Cost-effectiveness analysis of pembrolizumab plus chemotherapy for patients with recurrent or metastatic cervical cancer in China. Curr Med Res Opin. 2023;39(3):433\u201340.","journal-title":"Curr Med Res Opin"},{"key":"16449_CR22","doi-asserted-by":"publisher","first-page":"1476256","DOI":"10.3389\/fphar.2024.1476256","volume":"15","author":"H Cai","year":"2024","unstructured":"Cai H, et al. Atezolizumab plus bevacizumab and chemotherapy versus bevacizumab plus chemotherapy for metastatic cervical cancer: a cost-effectiveness analysis. Front Pharmacol. 2024;15:1476256.","journal-title":"Front Pharmacol"},{"issue":"3","key":"16449_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.ygyno.2013.02.012","volume":"129","author":"JL Lesnock","year":"2013","unstructured":"Lesnock JL, et al. Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysis. Gynecol Oncol. 2013;129(3):574\u20139.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"16449_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S1053-4296(05)80108-0","volume":"4","author":"TW Burke","year":"1994","unstructured":"Burke TW. Treatment Options in Stage IB Cervical Cancer: Radical Hysterectomy and Radiotherapy. Semin Radiat Oncol. 1994;4(1):34\u201340.","journal-title":"Semin Radiat Oncol"},{"issue":"4","key":"16449_CR25","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1097\/00003081-199012000-00023","volume":"33","author":"GJ Photopulos","year":"1990","unstructured":"Photopulos GJ. Surgery or radiation for early cervical cancer. Clin Obstet Gynecol. 1990;33(4):872\u201382.","journal-title":"Clin Obstet Gynecol"},{"issue":"23","key":"16449_CR26","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1200\/JCO.2009.23.1183","volume":"27","author":"NJ Meropol","year":"2009","unstructured":"Meropol NJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;27(23):3868\u201374.","journal-title":"J Clin Oncol"},{"issue":"7","key":"16449_CR27","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1097\/IGC.0000000000000749","volume":"26","author":"W Wang","year":"2016","unstructured":"Wang W, et al. Long-Term Oncological Outcomes After Laparoscopic Versus Abdominal Radical Hysterectomy in Stage IA2 to IIA2 Cervical Cancer: A Matched Cohort Study. Int J Gynecol Cancer. 2016;26(7):1264\u201373.","journal-title":"Int J Gynecol Cancer"},{"issue":"1","key":"16449_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1002\/jso.23347","volume":"108","author":"JY Park","year":"2013","unstructured":"Park JY, et al. Laparoscopic versus open radical hysterectomy in patients with stage IB2 and IIA2 cervical cancer. J Surg Oncol. 2013;108(1):63\u20139.","journal-title":"J Surg Oncol"},{"issue":"4","key":"16449_CR29","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1093\/annonc\/mdr360","volume":"23","author":"JH Nam","year":"2012","unstructured":"Nam JH, et al. Laparoscopic versus open radical hysterectomy in early-stage cervical cancer: long-term survival outcomes in a matched cohort study. Ann Oncol. 2012;23(4):903\u201311.","journal-title":"Ann Oncol"},{"issue":"7","key":"16449_CR30","doi-asserted-by":"publisher","first-page":"4516","DOI":"10.1097\/JS9.0000000000002522","volume":"111","author":"X Yang","year":"2025","unstructured":"Yang X, et al. Laparoscopic radical hysterectomy with Karez technique for stage IB3 and IIA2 cervical cancer: a multicenter retrospective cohort study. Int J Surg. 2025;111(7):4516\u201327.","journal-title":"Int J Surg"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16449-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16449-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:03:22Z","timestamp":1790078602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16449-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16449"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16449-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9161019\/v1","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"18 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This protocol has received approval from the Ethics Committees of the Obstetrics and Gynecology Hospital of Fudan University (No. 2021-12), Fudan University Shanghai Cancer Center (No. 2209260-24), and The Sixth Hospital of Shanghai Jiao Tong University School of Medicine (No. 2022-KY-150 (K)). The trial will adhere to Good Clinical Practice (GCP) standards and be conducted following the principles outlined in the World Medical Association\u2019s Declaration of Helsinki. Written informed consent were obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1129"}}